XM does not provide services to residents of the United States of America.

Top of the Street: Aena, Ashtead Group, Coloplast, Evonik, IAG



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ -Top of the Street: Aena, Ashtead Group, Coloplast, Evonik, IAG</title></head><body>

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:


** UBS and Deutsche Bank cut their ratings on Spanish airport operator Aena AENA.MC by one notch to "neutral" and "sell," respectively, seeing limited scope for are-rating in the near term

** Goldman Sachs downgrades Ashtead Group AHT.L to "neutral" from "buy" following theBritish equipment rental company's Q2 missand guidance cut, seeing risks to revenue growth for FY 2025 and FY26

** UBS raises Denmark's Coloplast Colob.CO to "neutral" from "sell," seeing the risk-reward for the medical equipment maker's shares as"better matched" now

** Morgan Stanley cuts Germany's Evonik EVKn.DE to "underweight" from "equal weight" as it sees limited near-term profit recovery scope, in contrast toits chemical producers peers

** Deutsche Bank raises Britain's International Airlines Group ICAG.L to "buy" from "hold" as it anticipates further progress on pricing in 2025 thanks to constrained capacity on the Transatlantic route, a key market for the British Airways- owner

** J.P. Morgan raises France's Publicis PUBP.PA to "overweight" from "neutral" as it expects the media group's strong US exposure to drive more than 5%growth, triple that ofits peers


(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)




Reporting by Philippe Leroy Beaulieu and Joao Manuel Mauricio

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.